Quote:

---

Short version: if a company licenses the rights to sell Leron, then no matter what ICI is paired with Leron, that licensing company makes money from the sale.

They own Leron for that indication, or co-own it. So of course they would want to license it.

---

Licensing for one indication has never made sense. A large pharma may license it for all indications but at that point it would be better for them if they just bought Cytodyn.